Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection

ZHENG Ming-ying; ZHOU Qing

doi:10.12019/j.issn.1671-5144.2021.01.015

ZHENG Ming-ying, ZHOU Qing. Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 60-64. DOI: 10.12019/j.issn.1671-5144.2021.01.015

Citation:

ZHENG Ming-ying, ZHOU Qing. Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 60-64. DOI: 10.12019/j.issn.1671-5144.2021.01.015

Citation:

ZHENG Ming-ying, ZHOU Qing. Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 60-64. DOI: 10.12019/j.issn.1671-5144.2021.01.015

Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection

Graphical Abstract

Abstract

FullText(HTML)

References (2)

Therapeutic Strategy for Patients with Non-Small Cell Lung Cancer Complicated with Lung Abscess Infection

Catalog

Export File

Citation

Format

Content